Bojmar's lab
@bojmarlab.bsky.social
#CancerResearch at Linköping University and Weill Cornell
@liucancer.bsky.social
Led by Assistant Professor and Docent Linda Bojmar
Understanding organ crosstalk and its impact on cancer metastasis.
@liucancer.bsky.social
Led by Assistant Professor and Docent Linda Bojmar
Understanding organ crosstalk and its impact on cancer metastasis.
🧫 🩺 Meet Chuanwen Fan
He researches the mechanisms driving therapy resistance and metastasis in gastrointestinal cancers, focusing particularly on how stemness- and plasticity-associated cancer cell states and the primary tumor secretome, including tumor EVs, shape metastatic progression.
He researches the mechanisms driving therapy resistance and metastasis in gastrointestinal cancers, focusing particularly on how stemness- and plasticity-associated cancer cell states and the primary tumor secretome, including tumor EVs, shape metastatic progression.
November 18, 2025 at 8:22 PM
🧫 🩺 Meet Chuanwen Fan
He researches the mechanisms driving therapy resistance and metastasis in gastrointestinal cancers, focusing particularly on how stemness- and plasticity-associated cancer cell states and the primary tumor secretome, including tumor EVs, shape metastatic progression.
He researches the mechanisms driving therapy resistance and metastasis in gastrointestinal cancers, focusing particularly on how stemness- and plasticity-associated cancer cell states and the primary tumor secretome, including tumor EVs, shape metastatic progression.
🧫 🩺 Meet Håkon Andersen Blomstrand
Pathologist, MD PhD
Originally from Uppsala, Håkon earned his medical degree at Gothenburg in 2013 and his PhD last year at Linköping's University.
Pathologist, MD PhD
Originally from Uppsala, Håkon earned his medical degree at Gothenburg in 2013 and his PhD last year at Linköping's University.
November 14, 2025 at 4:07 PM
🧫 🩺 Meet Håkon Andersen Blomstrand
Pathologist, MD PhD
Originally from Uppsala, Håkon earned his medical degree at Gothenburg in 2013 and his PhD last year at Linköping's University.
Pathologist, MD PhD
Originally from Uppsala, Håkon earned his medical degree at Gothenburg in 2013 and his PhD last year at Linköping's University.
🧬 Meet Carolin Jönsson
Research Engineer
Born in southern Germany, Carolin trained at the Max‑Planck Institute and later worked in Switzerland and Toronto before moving to Sweden in 1993.
Research Engineer
Born in southern Germany, Carolin trained at the Max‑Planck Institute and later worked in Switzerland and Toronto before moving to Sweden in 1993.
November 14, 2025 at 4:05 PM
🧬 Meet Carolin Jönsson
Research Engineer
Born in southern Germany, Carolin trained at the Max‑Planck Institute and later worked in Switzerland and Toronto before moving to Sweden in 1993.
Research Engineer
Born in southern Germany, Carolin trained at the Max‑Planck Institute and later worked in Switzerland and Toronto before moving to Sweden in 1993.
🩺 Meet Bergthor Björnsson
MD, PhD, Docent / Senior Consultant
Bergthor’s clinical and translational research centers on pancreatic and liver surgery—he has led randomized and multicenter trials at Linköping.
MD, PhD, Docent / Senior Consultant
Bergthor’s clinical and translational research centers on pancreatic and liver surgery—he has led randomized and multicenter trials at Linköping.
November 14, 2025 at 3:44 PM
🩺 Meet Bergthor Björnsson
MD, PhD, Docent / Senior Consultant
Bergthor’s clinical and translational research centers on pancreatic and liver surgery—he has led randomized and multicenter trials at Linköping.
MD, PhD, Docent / Senior Consultant
Bergthor’s clinical and translational research centers on pancreatic and liver surgery—he has led randomized and multicenter trials at Linköping.
🩺 Meet Per Sandström
Adjungerad professor, MD/PhD
Per’s research focuses on patients with liver, biliary tract, and pancreatic tumors, striving to refine the boundaries between treatment options and ensure equal access to assessment and care for all patients.
Adjungerad professor, MD/PhD
Per’s research focuses on patients with liver, biliary tract, and pancreatic tumors, striving to refine the boundaries between treatment options and ensure equal access to assessment and care for all patients.
November 14, 2025 at 2:11 PM
🩺 Meet Per Sandström
Adjungerad professor, MD/PhD
Per’s research focuses on patients with liver, biliary tract, and pancreatic tumors, striving to refine the boundaries between treatment options and ensure equal access to assessment and care for all patients.
Adjungerad professor, MD/PhD
Per’s research focuses on patients with liver, biliary tract, and pancreatic tumors, striving to refine the boundaries between treatment options and ensure equal access to assessment and care for all patients.
🧬 Meet Mohamed Elhusseiny
Post-doc Researcher
His work centers on cancer metabolism and metabolic reprogramming, with a focus on developing ex vivo and computational models to better understand tumor–host interactions.
Post-doc Researcher
His work centers on cancer metabolism and metabolic reprogramming, with a focus on developing ex vivo and computational models to better understand tumor–host interactions.
November 14, 2025 at 2:05 PM
🧬 Meet Mohamed Elhusseiny
Post-doc Researcher
His work centers on cancer metabolism and metabolic reprogramming, with a focus on developing ex vivo and computational models to better understand tumor–host interactions.
Post-doc Researcher
His work centers on cancer metabolism and metabolic reprogramming, with a focus on developing ex vivo and computational models to better understand tumor–host interactions.
🔬 Meet Alexander Sandberg
PhD, Principal Research Engineer
During his PhD he investigated amyloid-forming proteins in neurodegenerative disease. Since 2024, he has been part of Bojmar’s group, focusing on how EV’s shape the pre-metastatic niche in GI cancers.
PhD, Principal Research Engineer
During his PhD he investigated amyloid-forming proteins in neurodegenerative disease. Since 2024, he has been part of Bojmar’s group, focusing on how EV’s shape the pre-metastatic niche in GI cancers.
November 14, 2025 at 1:56 PM
🔬 Meet Alexander Sandberg
PhD, Principal Research Engineer
During his PhD he investigated amyloid-forming proteins in neurodegenerative disease. Since 2024, he has been part of Bojmar’s group, focusing on how EV’s shape the pre-metastatic niche in GI cancers.
PhD, Principal Research Engineer
During his PhD he investigated amyloid-forming proteins in neurodegenerative disease. Since 2024, he has been part of Bojmar’s group, focusing on how EV’s shape the pre-metastatic niche in GI cancers.
🩺 Meet Paulina Velasco Riestra
MD
Paulina earned her MD in Mexico City and began her research career at MD Anderson in pulmonary medicine.
MD
Paulina earned her MD in Mexico City and began her research career at MD Anderson in pulmonary medicine.
November 14, 2025 at 1:42 PM
🩺 Meet Paulina Velasco Riestra
MD
Paulina earned her MD in Mexico City and began her research career at MD Anderson in pulmonary medicine.
MD
Paulina earned her MD in Mexico City and began her research career at MD Anderson in pulmonary medicine.
🩺 Meet Constantinos Zambirinis
MD, MRes
Originally from Paphos, Cyprus. He completed surgical training and oncology fellowships across the U.S., and spent time at NYU and Memorial Sloan Kettering studying inflammation’s role in pancreatic cancer and the liver pre‑metastatic niche.
MD, MRes
Originally from Paphos, Cyprus. He completed surgical training and oncology fellowships across the U.S., and spent time at NYU and Memorial Sloan Kettering studying inflammation’s role in pancreatic cancer and the liver pre‑metastatic niche.
November 14, 2025 at 1:07 PM
🩺 Meet Constantinos Zambirinis
MD, MRes
Originally from Paphos, Cyprus. He completed surgical training and oncology fellowships across the U.S., and spent time at NYU and Memorial Sloan Kettering studying inflammation’s role in pancreatic cancer and the liver pre‑metastatic niche.
MD, MRes
Originally from Paphos, Cyprus. He completed surgical training and oncology fellowships across the U.S., and spent time at NYU and Memorial Sloan Kettering studying inflammation’s role in pancreatic cancer and the liver pre‑metastatic niche.
🩺 Meet Verena Unterkircher
MD
Raised in a small Alpine town in Northern Italy, Verena graduated from Medical University of Innsbruck in 2024, where she engaged in vascular surgery research and teaching.
MD
Raised in a small Alpine town in Northern Italy, Verena graduated from Medical University of Innsbruck in 2024, where she engaged in vascular surgery research and teaching.
November 14, 2025 at 1:05 PM
🩺 Meet Verena Unterkircher
MD
Raised in a small Alpine town in Northern Italy, Verena graduated from Medical University of Innsbruck in 2024, where she engaged in vascular surgery research and teaching.
MD
Raised in a small Alpine town in Northern Italy, Verena graduated from Medical University of Innsbruck in 2024, where she engaged in vascular surgery research and teaching.
🩺 Meet Erik Lundqvist
MD, Surgical Consultant, PhD.
A native of Söderköping, Erik studied medicine at Linköping. The overall aim with his research is to improve the diagnosis and management of patients with colorectal cancer, affecting almost 7000 new individuals in Sweden each year.
MD, Surgical Consultant, PhD.
A native of Söderköping, Erik studied medicine at Linköping. The overall aim with his research is to improve the diagnosis and management of patients with colorectal cancer, affecting almost 7000 new individuals in Sweden each year.
September 5, 2025 at 12:04 PM
🩺 Meet Erik Lundqvist
MD, Surgical Consultant, PhD.
A native of Söderköping, Erik studied medicine at Linköping. The overall aim with his research is to improve the diagnosis and management of patients with colorectal cancer, affecting almost 7000 new individuals in Sweden each year.
MD, Surgical Consultant, PhD.
A native of Söderköping, Erik studied medicine at Linköping. The overall aim with his research is to improve the diagnosis and management of patients with colorectal cancer, affecting almost 7000 new individuals in Sweden each year.
🩺️ Meet Karin Johansen
MD, PhD
From Gothenburg, Karin graduated from Linköping’s medical school in 2018. Her PhD was in pancreatic surgery, cost‑effectiveness, and quality of life.
MD, PhD
From Gothenburg, Karin graduated from Linköping’s medical school in 2018. Her PhD was in pancreatic surgery, cost‑effectiveness, and quality of life.
September 5, 2025 at 11:59 AM
🩺️ Meet Karin Johansen
MD, PhD
From Gothenburg, Karin graduated from Linköping’s medical school in 2018. Her PhD was in pancreatic surgery, cost‑effectiveness, and quality of life.
MD, PhD
From Gothenburg, Karin graduated from Linköping’s medical school in 2018. Her PhD was in pancreatic surgery, cost‑effectiveness, and quality of life.
🔬 Meet Jonas Burman
PhD candidate
Raised in Karlstad, Jonas moved to Linköping for his bachelor's in biology and later completed a master’s in Experimental & Medical Biosciences in 2022. He did an international exchange in the Lyden lab, at Weill Cornell Medicine in New York.
PhD candidate
Raised in Karlstad, Jonas moved to Linköping for his bachelor's in biology and later completed a master’s in Experimental & Medical Biosciences in 2022. He did an international exchange in the Lyden lab, at Weill Cornell Medicine in New York.
September 5, 2025 at 11:56 AM
🔬 Meet Jonas Burman
PhD candidate
Raised in Karlstad, Jonas moved to Linköping for his bachelor's in biology and later completed a master’s in Experimental & Medical Biosciences in 2022. He did an international exchange in the Lyden lab, at Weill Cornell Medicine in New York.
PhD candidate
Raised in Karlstad, Jonas moved to Linköping for his bachelor's in biology and later completed a master’s in Experimental & Medical Biosciences in 2022. He did an international exchange in the Lyden lab, at Weill Cornell Medicine in New York.
🩺 Meet Elena Arlaman
MD, PhD candidate
Elena was born and raised from Syria and studied pharmacy at Damascus University before relocating to Sweden in 2014, and completing MD training at Linköping University. She's currently an oncology resident and researcher.
MD, PhD candidate
Elena was born and raised from Syria and studied pharmacy at Damascus University before relocating to Sweden in 2014, and completing MD training at Linköping University. She's currently an oncology resident and researcher.
September 5, 2025 at 11:49 AM
🩺 Meet Elena Arlaman
MD, PhD candidate
Elena was born and raised from Syria and studied pharmacy at Damascus University before relocating to Sweden in 2014, and completing MD training at Linköping University. She's currently an oncology resident and researcher.
MD, PhD candidate
Elena was born and raised from Syria and studied pharmacy at Damascus University before relocating to Sweden in 2014, and completing MD training at Linköping University. She's currently an oncology resident and researcher.
🧪 Meet Linda Bojmar
PhD, Assistant Professor, Docent
Linda trained in Linköping and completed her post‑doc at Weill Cornell, focusing on extracellular vesicles and cancer progression.
PhD, Assistant Professor, Docent
Linda trained in Linköping and completed her post‑doc at Weill Cornell, focusing on extracellular vesicles and cancer progression.
September 5, 2025 at 11:43 AM
🧪 Meet Linda Bojmar
PhD, Assistant Professor, Docent
Linda trained in Linköping and completed her post‑doc at Weill Cornell, focusing on extracellular vesicles and cancer progression.
PhD, Assistant Professor, Docent
Linda trained in Linköping and completed her post‑doc at Weill Cornell, focusing on extracellular vesicles and cancer progression.
From our lab, Linda presented a talk on the hepatic #preMetastatic niche in #pancreaticcancer and how systemic effects of cancer may serve as biomarkers for metastasis.
Meanwhile, Mohamed, @jonasburman.bsky.social, and Verena contributed with poster presentations showcasing their exciting work!
Meanwhile, Mohamed, @jonasburman.bsky.social, and Verena contributed with poster presentations showcasing their exciting work!
June 24, 2025 at 1:02 PM
From our lab, Linda presented a talk on the hepatic #preMetastatic niche in #pancreaticcancer and how systemic effects of cancer may serve as biomarkers for metastasis.
Meanwhile, Mohamed, @jonasburman.bsky.social, and Verena contributed with poster presentations showcasing their exciting work!
Meanwhile, Mohamed, @jonasburman.bsky.social, and Verena contributed with poster presentations showcasing their exciting work!
This year was the 7th Swedish Cancer Research Meeting #SCRM and for the first time @liu.se @liucancer.bsky.social took part in the national programme committee. A big thanks to Lund University Cancer Centre @lunduniversity.bsky.social for hosting this year’s gathering! This is our lab's insight:
June 24, 2025 at 1:02 PM
This year was the 7th Swedish Cancer Research Meeting #SCRM and for the first time @liu.se @liucancer.bsky.social took part in the national programme committee. A big thanks to Lund University Cancer Centre @lunduniversity.bsky.social for hosting this year’s gathering! This is our lab's insight:
Recently, we got to celebrate our postdoc Mohamed Elhusseiny. 2025 grant awardee from Dr Per Håkansson’s Foundation for Research!
With this grant, we will explore a unique metabolic vulnerability in cancer cells: methionine dependency.
Did you know that cancer cells are addicted to methionine? 👀
With this grant, we will explore a unique metabolic vulnerability in cancer cells: methionine dependency.
Did you know that cancer cells are addicted to methionine? 👀
June 18, 2025 at 11:55 AM
Recently, we got to celebrate our postdoc Mohamed Elhusseiny. 2025 grant awardee from Dr Per Håkansson’s Foundation for Research!
With this grant, we will explore a unique metabolic vulnerability in cancer cells: methionine dependency.
Did you know that cancer cells are addicted to methionine? 👀
With this grant, we will explore a unique metabolic vulnerability in cancer cells: methionine dependency.
Did you know that cancer cells are addicted to methionine? 👀
Verena Unterkircher was awarded the Young Cancer Research Award by the Swedish Cancer Association PALEMA. Thanks to this grant, she’ll keep pushing forward her project on identifying biomarkers for pancreatic cancer. 🔬✨ #cancerresearch #womeninscience
June 18, 2025 at 11:21 AM
Verena Unterkircher was awarded the Young Cancer Research Award by the Swedish Cancer Association PALEMA. Thanks to this grant, she’ll keep pushing forward her project on identifying biomarkers for pancreatic cancer. 🔬✨ #cancerresearch #womeninscience
"Once the tumour has spread to the liver, most patients unfortunately end up dying from the metastatic disease. One of the goals of this study was to try to capture early steps in the initiation of liver metastasis." -Constantinos Zambirinis
June 17, 2025 at 12:47 PM
"Once the tumour has spread to the liver, most patients unfortunately end up dying from the metastatic disease. One of the goals of this study was to try to capture early steps in the initiation of liver metastasis." -Constantinos Zambirinis
The most interesting thing is that there are differences in the liver depending on how the patients are progressing. We see markers for various changes that seem to have an impact on the spread of cancer, and that will be very exciting to follow up in expanded studies.
June 17, 2025 at 12:47 PM
The most interesting thing is that there are differences in the liver depending on how the patients are progressing. We see markers for various changes that seem to have an impact on the spread of cancer, and that will be very exciting to follow up in expanded studies.
A liver biopsy may predict spread of pancreatic cancer.
This discovery holds the potential to improve how we anticipate disease progression and prevent pancreatic cancer from spreading to other organs.
This discovery holds the potential to improve how we anticipate disease progression and prevent pancreatic cancer from spreading to other organs.
June 17, 2025 at 12:47 PM
A liver biopsy may predict spread of pancreatic cancer.
This discovery holds the potential to improve how we anticipate disease progression and prevent pancreatic cancer from spreading to other organs.
This discovery holds the potential to improve how we anticipate disease progression and prevent pancreatic cancer from spreading to other organs.
We had the opportunity to take part in the very first Swedish Extracellular Vesicles Network meeting in Stockholm! 🧬
We presented our latest findings on cancer EVs as mediators of systemic disease. We got to say hejhej to our friend and colleague, David Lyden, who came all the way from New York!
We presented our latest findings on cancer EVs as mediators of systemic disease. We got to say hejhej to our friend and colleague, David Lyden, who came all the way from New York!
June 17, 2025 at 12:17 PM
We had the opportunity to take part in the very first Swedish Extracellular Vesicles Network meeting in Stockholm! 🧬
We presented our latest findings on cancer EVs as mediators of systemic disease. We got to say hejhej to our friend and colleague, David Lyden, who came all the way from New York!
We presented our latest findings on cancer EVs as mediators of systemic disease. We got to say hejhej to our friend and colleague, David Lyden, who came all the way from New York!